Bioidentical hormones

Climacteric. 2021 Feb;24(1):38-45. doi: 10.1080/13697137.2020.1862079. Epub 2021 Jan 6.

Abstract

After the results of the Women's Health Initiative trials were published, patient and clinician interest in potential alternatives to conventional hormone therapy (HT) has grown. A commonly used alternative therapy involves custom-compounded steroid hormone preparations, formulated by compounding pharmacies. Many postmenopausal women consider the hormones as natural or bioidentical, in contrast to hormones used in conventional HT, which they consider synthetic. In actuality, the chemical structures of many of the hormones used in bioidentical HT (BHT) are the same as those used in conventional HT. To customize formulations, compounding pharmacies frequently use saliva testing to measure hormones. However, there is a misconception that salivary hormone levels are equivalent to non-protein-bound (free) hormones in blood. Because hormonal custom-compounded formulations are not approved by the Food and Drug Administration (FDA), there are concerns regarding their purity, potency, and quality. Evolving regulatory guidelines by the FDA on oversight of these products should lessen the concerns regarding their safety and efficacy. This review addresses important misconceptions and uncertainties pertaining to BHT, the relationship between salivary and serum/plasma steroid hormone concentrations, the effect of topical progesterone creams on the endometrium, the variability in custom-compounded steroid preparations, and FDA oversight of custom-compounded products.

Keywords: Bioidentical; compounding; estrogens; postmenopause; progesterone; salivary testing.

Publication types

  • Review

MeSH terms

  • Drug Compounding / standards*
  • Estrogens / blood
  • Estrogens / metabolism
  • Female
  • Hormone Replacement Therapy*
  • Humans
  • Menopause*
  • Saliva / metabolism
  • United States
  • United States Food and Drug Administration

Substances

  • Estrogens